Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1351 clinical trials
Accelerometer Sensing for Micra AV Study

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

atrioventricular block
  • 0 views
  • 19 Feb, 2024
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

memantine
galantamine
amyloidosis
positron emission tomography
alzheimer's disease
  • 0 views
  • 19 Feb, 2024
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Participants will get once daily injections of either NNC0472-0147 or insulin glargine for a treatment period of fourteen days. The injections will be given under the skin (subcutaneously, s.c.) of the left thigh. Participants will be in the study for about 7 weeks. There will be 15 visits with the …

low density lipoprotein
diabetes
oophorectomy
type 2 diabetes mellitus
bilateral oophorectomy
  • 0 views
  • 19 Feb, 2024
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand

Results of tracer uptake and MRI image features as whole body PET/MRI and dedicated pelvic/prostate PET/MRI, alone and together, will be correlated and compared to detection of lesions on conventional imaging modalities. Additionally, if the patient undergoes a biopsy as standard of care, image features will correlate directly with histopathological …

metastasis
MRI
conventional imaging
prostate specific antigen
localized disease
  • 0 views
  • 19 Feb, 2024
Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness and Parental Substance Use

Our primary hypothesis is that the adapted family resilience program will be feasible and acceptable to families with a recent history of homelessness and parental substance use disorder. Families that are eligible to participate in the study will be assigned randomly to one of two groups, 1) adapted family resilience …

  • 0 views
  • 19 Feb, 2024
Mobile App as a Guide to Exercises for Patients With Chronic Stroke

Even if chronicity leads us to think about the stabilization of the physical condition, It is thought that the best results will be found among the subjects who will use the App.

physical rehabilitation
hemiplegia or hemiparesis
hemiplegia
hemiparesis
stroke
  • 0 views
  • 19 Feb, 2024
Test Food4GutMarKIT - Evaluation of a Tailored Personalized Food Concept for a Healthy Gut Microbiota and Validation of Biomarkers for Monitoring of Its Effects  

The study will be running over 18 weeks (including a 6-week wash-out period) and it will include 9 visits at the clinic.

Accepts healthy volunteers
  • 0 views
  • 19 Feb, 2024
  • 3 locations
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

screening procedures
measurable disease
HER2
endocrine therapy
solid tumour
  • 0 views
  • 19 Feb, 2024
A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS CMML or AML

Phase 3 is a randomized open-label crossover study comparing the final oral ASTX030 tablet to SC azacitidine. The duration of the study is expected to be approximately 36 months.

acute myeloid leukemia
dysplasia
graft versus host disease
ringed sideroblasts
chronic myelomonocytic leukemia
  • 0 views
  • 19 Feb, 2024
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

KEAP1/NRF2 mutation status (for eligibility) and STK11/LKB1 status (for stratification) will be determined by next generation sequencing. A commercial liquid biopsy (circulating tumor DNA) NGS test will be provided to study participants free of charge.

metastasis
NTRK
BRAF
measurable disease
pembrolizumab
  • 0 views
  • 19 Feb, 2024